LONFUTRI
LIVE

Serial Number

99918600

Owner

Intellia Therapeutics, Inc.

Attorney

Karen K. Won

Filing Date

Jul 2, 2026

Add to watchlist:

No watchlists yet
View on USPTO

LONFUTRI Trademark

Serial Number: 99918600

LONFUTRI is a trademark filed by Intellia Therapeutics, Inc. on July 2, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Intellia Therapeutics, Inc. (16 trademarks)

40 Erie Street
Cambridge, MA 02139

Entity Type: 03

Trademark Details

Filing Date

July 2, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical and biological preparations; Pharmaceutical and biological preparations for use as a gene editing therapy; Pharmaceutical preparations for the treatment of hereditary angioedema; Pharmaceutical and biological preparations for treating and managing hereditary angioedema (HAE) and complications caused by hereditary angioedema (HAE); Pharmaceutical and biological preparations for use as a one-time treatment for hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency (Type 1 or Type 2); Pharmaceutical and biological preparations for use as a gene editing therapy that inactivates the KLKB1 gene and lowers plasma prekallikrein levels; Pharmaceutical and biological preparations for use as a gene editing therapy for hereditary angioedema (HAE); Pharmaceutical and biological preparations, namely, gene editing preparations for treating and managing swelling attacks; Therapeutic agents in the nature of a CRISPR/Cas9 system for treating hereditary angioedema (HAE)

Filing History

APPLICATION FILING RECEIPT MAILED
Jul 2, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 2, 2026 NWOS
NEW APPLICATION ENTERED
Jul 2, 2026 NWAP